Ernst & Young is appointed as valuer for Nokia India's Chennai mobile making plant
India will beat China, North America and Europe to become the fastest growing automobile market.
Despite regulatory hurdles, India continues to be among the preferred destinations for FDI due to the country's high economic growth, with both Mumbai and Delhi being touted as among the cities likely to produce the next Microsoft or Google, a survey said.
Describing the annual monetary policy announced by RBI Governor D Subbarao as a progressive one, Ernst & Young India's Ashvin Parekh said, "We have almost reached a point where inflation has become unmanageable and RBI has clearly indicated that bringing down inflation to a comfortable level is its top priority."
Ernst & Young India on Tuesday said that despite the steep fall in headline inflation in August, the Reserve Bank is likely to persist with monetary tightening measures by hiking key policy rates by at least 25 basis points at its mid-quarter review on Thursday.
Auditing firms in the country could soon run out of business if they do not get themselves verified according to the guidelines mentioned in the Eighth Directive issued by the European Union (EU). EU will recognise balance-sheets of companies audited by firms that fit their specified standards.
India's burgeoning entertainment industry loses as much as $ 4 billion and 800,000 direct jobs each year due to counterfeiting and piracy, a latest study says. The study -- The effects of counterfeiting & piracy on India's entertainment industry -- was prepared by Ernst & Young India. It was commissioned as part of the USIBC-FICCI Bollywood-Hollywood Initiative, which promotes the sustainable growth & convergence underway between the entertainment industries of the US & India
Exercise at least 45 minutes every day -- brisk walking, running, cycling or any other form of physical activity is beneficial, says Dr Naresh Trehan.
Nokia's Chennai plant is under freeze over tax dispute.
The capital outlay to cover the modernisation programmes have got a hike of 10.05 per cent.
Since 2013, the FDA has banned around 30 Indian drug manufacturing units for various violations